BioNxt Solutions Inc. (CVE:BNXT) | WebDisclosure

Basculer en Français

10624	Companies
225765	Keywords
154324	Articles
119465	Press releases

Headlines Articles Press releases BioNxt Solutions Inc.

Home
Companies
BioNxt Solutions Inc.

PRESS RELEASE

published on 09/09/2024 at 22:30, 1 year 9 months ago

BioNxt Receives Positive International Examination Report From the European Patent Office for Broad Patent Application for Sublingual Delivery of Anticancer Drugs for the Treatment of Autoimmune Neurodegenerative Diseases
BioNxt Solutions Inc. receives positive international examination report from the European Patent Office for sublingual delivery patent application. Company to expand patent portfolio for neurodegenerative diseases and MS market

BioNxt Solutions Inc. Multiple Sclerosis Patent Application Neurodegenerative Diseases European Patent Office
BRIEF

published on 08/15/2024 at 09:10, 1 year 10 months ago

BioNxt Signs Letter of Intent with Gen-Plus GmbH & Co KG for Potential Business Collaborations

Partnership Cladribine Pharmaceutical Development BioNxt Solutions Gen-Plus GmbH
BRIEF

published on 08/15/2024 at 09:10, 1 year 10 months ago

BioNxt signe une lettre d'intention avec Gen-Plus GmbH & Co KG pour d'éventuelles collaborations commerciales

Partenariat Cladribine Développement Pharmaceutique Solutions BioNxt Gen-Plus GmbH
PRESS RELEASE

published on 08/15/2024 at 09:05, 1 year 10 months ago

BioNxt Signs Letter of Intent with Gen-Plus GmbH & Co KG for Potential Business Collaborations
BioNxt Solutions Inc. signs non-binding LOI with Gen-Plus GmbH & Co KG, part of Conscio Group, for potential cooperation in pharmaceutical products and clinical trials. Details to follow

Clinical Trials Pharmaceutical BioNxt Solutions Inc. LOI Gen-Plus GmbH
BRIEF

published on 07/17/2024 at 09:10, 1 year 11 months ago

BioNxt Signs Statement of Work with International CRDMO for Cladribine ODF Development

Multiple Sclerosis Pharmaceutical Development BioNxt Solutions Cladribine ODF CRDMO
BRIEF

published on 07/17/2024 at 09:10, 1 year 11 months ago

BioNxt signe une déclaration de travail avec le CRDMO international pour le développement de la cladribine ODF

Sclérose En Plaques Développement Pharmaceutique Solutions BioNxt Cladribine ODF CRDMO
PRESS RELEASE

published on 07/17/2024 at 09:05, 1 year 11 months ago

BioNxt Signs Statement of Work with International Contract Research, Development, And Manufacturing Organization for Cladribine ODF Development
BioNxt Solutions Inc. signs agreement with German CRDMO for Cladribine oral dissolvable film development program targeting the lucrative multiple sclerosis market

BioNxt Solutions Inc. Cladribine CRDMO Oral Dissolvable Film MS Market
BRIEF

published on 07/09/2024 at 09:10, 1 year 11 months ago

BioNxt Signs Master Services Agreement with International Contract Research, Development, and Manufacturing Organization

Drug Development Pharmaceutical Market Master Services Agreement BioNxt Solutions Cladribine ODF
BRIEF

published on 07/09/2024 at 09:10, 1 year 11 months ago

BioNxt signe un accord-cadre de services avec une organisation internationale de recherche, de développement et de fabrication sous contrat

Marché Pharmaceutique Développement De Médicaments Solutions BioNxt Cladribine ODF Contrat-cadre De Services
PRESS RELEASE

published on 07/09/2024 at 09:05, 1 year 11 months ago

BioNxt Signs Master Services Agreement with International Contract Research, Development, and Manufacturing Organization
BioNxt Solutions Inc. signs master services agreement with German-based CRDMO for product development of oral dissolvable drug formulations

BioNxt Solutions Inc. Product Development Master Services Agreement CRDMO Oral Dissolvable Drug Formulations

Accesswire

Published on 06/24/2026 at 03:15, 6 hours 26 minutes ago

Noram Lithium Adopts Semi-Annual Financial Reporting
Published on 06/24/2026 at 00:00, 9 hours 41 minutes ago

Onco-Innovations Engages Nanosoft Polymers to Advance Polymer and Drug Delivery Development for ONC010
Published on 06/23/2026 at 23:45, 9 hours 56 minutes ago

Prospect Ridge Aligns with the Market Mindset for Exclusive Live Investor Interview Discussing Game-changing 2026 Drill Programs
Published on 06/23/2026 at 23:20, 10 hours 21 minutes ago

BioNxt Announces Closing of Non-brokered Private Placement of Units Pursuant to the Listed Issuer Exemption
Published on 06/23/2026 at 23:15, 10 hours 26 minutes ago

EV Nickel Signs LOI Forming High-Grade Nickel Joint Venture for Shaw Dome Projects

View all ACCESSWIRE

EQS Group

Published on 06/24/2026 at 09:37, 4 minutes ago

KNDS ANNOUNCES INTENTION TO PROCEED WITH AN IPO TO SUPPORT ITS LONG-TERM GROWTH STRATEGY
Published on 06/24/2026 at 09:34, 6 minutes ago

Turkiye Garanti Bankasi A.S.: CMB Approval for Bond Issuance to Foreign Markets
Published on 06/24/2026 at 09:11, 30 minutes ago

The Platform Group to Host Strategy & Update Call
Published on 06/24/2026 at 09:00, 41 minutes ago

official list notice
Published on 06/24/2026 at 09:00, 41 minutes ago

Yellow Card Can Now Offer Regulated Virtual Asset and Related Services from Switzerland

Les Echos

Published on 06/24/2026 at 09:30, 11 minutes ago

CP HOPENING - Le 1er Baromètre “Libéralités - Grande Transmission”
Published on 06/23/2026 at 19:47, 13 hours 53 minutes ago

GROUPE SFPI: reorganisation de la Direction Générale
Published on 06/23/2026 at 19:47, 13 hours 53 minutes ago

GROUPE SFPI: General management reorganisation
Published on 06/23/2026 at 19:10, 14 hours 31 minutes ago

GUILLEMOT CORPORATION > EVOLUTION DE LA GOUVERNANCE A COMPTER DU 23 JUIN 2026
Published on 06/23/2026 at 19:10, 14 hours 31 minutes ago

GUILLEMOT CORPORATION: Changes to Corporate Governance Effective June 23, 2026

View all LES ECHOS COMFI WIRE